COMPOSITION FOR THE TREATMENT OF COVID-19
Application
US20260076979A1
Kind: A1
Mar 19, 2026
Inventors
Albert Nguyen
Abstract
A composition for the treatment of COVID-19 is disclosed, including a first composition including approximately 10 mg of dexamethasone. The first composition is combined with a second composition including between approximately 48 mg to approximately 80 mg of triamcinolone acetonide, sodium chloride, benzyl alcohol, carboxymethylcellulose sodium, and polysorbate 80.
CPC Classifications
A61K 31/573
A61K 9/0019
A61K 47/10
A61K 47/26
A61K 47/38
Filing Date
2024-09-19
Application No.
18890710